nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP1A1—Cholecalciferol—osteoporosis	0.08	0.117	CbGbCtD
Norfloxacin—CYP1A2—Estropipate—osteoporosis	0.0694	0.102	CbGbCtD
Norfloxacin—CYP1A1—Estradiol—osteoporosis	0.0645	0.0945	CbGbCtD
Norfloxacin—SLC22A6—Conjugated Estrogens—osteoporosis	0.0644	0.0944	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0516	0.0756	CbGbCtD
Norfloxacin—CYP3A7—Estradiol—osteoporosis	0.0516	0.0756	CbGbCtD
Norfloxacin—CYP3A5—Estradiol—osteoporosis	0.0387	0.0567	CbGbCtD
Norfloxacin—CYP3A4—Estropipate—osteoporosis	0.0363	0.0533	CbGbCtD
Norfloxacin—CYP3A4—Calcitriol—osteoporosis	0.0363	0.0533	CbGbCtD
Norfloxacin—CYP1A2—Conjugated Estrogens—osteoporosis	0.0328	0.0481	CbGbCtD
Norfloxacin—CYP3A4—Ergocalciferol—osteoporosis	0.0291	0.0426	CbGbCtD
Norfloxacin—CYP1A2—Estradiol—osteoporosis	0.0288	0.0422	CbGbCtD
Norfloxacin—CYP3A4—Raloxifene—osteoporosis	0.0242	0.0355	CbGbCtD
Norfloxacin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0234	0.0343	CbGbCtD
Norfloxacin—CYP3A4—Cholecalciferol—osteoporosis	0.0187	0.0274	CbGbCtD
Norfloxacin—CYP3A4—Conjugated Estrogens—osteoporosis	0.0172	0.0252	CbGbCtD
Norfloxacin—CYP3A4—Estradiol—osteoporosis	0.0151	0.0221	CbGbCtD
Norfloxacin—TOP2A—Fulvestrant—Estradiol—osteoporosis	0.00136	0.337	CbGdCrCtD
Norfloxacin—TOP2A—Levorphanol—Estradiol—osteoporosis	0.000896	0.222	CbGdCrCtD
Norfloxacin—TOP2A—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.000818	0.203	CbGdCrCtD
Norfloxacin—TOP2A—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000533	0.132	CbGdCrCtD
Norfloxacin—TOP2A—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000424	0.105	CbGdCrCtD
Norfloxacin—Vision blurred—Conjugated Estrogens—osteoporosis	0.000322	0.00104	CcSEcCtD
Norfloxacin—Urticaria—Ibandronate—osteoporosis	0.000322	0.00103	CcSEcCtD
Norfloxacin—Abdominal pain—Ibandronate—osteoporosis	0.00032	0.00103	CcSEcCtD
Norfloxacin—Body temperature increased—Ibandronate—osteoporosis	0.00032	0.00103	CcSEcCtD
Norfloxacin—Confusional state—Pamidronate—osteoporosis	0.00032	0.00103	CcSEcCtD
Norfloxacin—Vertigo—Zoledronate—osteoporosis	0.000319	0.00103	CcSEcCtD
Norfloxacin—Leukopenia—Zoledronate—osteoporosis	0.000318	0.00102	CcSEcCtD
Norfloxacin—Oedema—Pamidronate—osteoporosis	0.000317	0.00102	CcSEcCtD
Norfloxacin—Anaphylactic shock—Pamidronate—osteoporosis	0.000317	0.00102	CcSEcCtD
Norfloxacin—Urticaria—Calcitriol—osteoporosis	0.000315	0.00101	CcSEcCtD
Norfloxacin—Hepatitis—Estradiol—osteoporosis	0.000314	0.00101	CcSEcCtD
Norfloxacin—Palpitations—Zoledronate—osteoporosis	0.000314	0.00101	CcSEcCtD
Norfloxacin—Abdominal pain—Calcitriol—osteoporosis	0.000314	0.00101	CcSEcCtD
Norfloxacin—Body temperature increased—Calcitriol—osteoporosis	0.000314	0.00101	CcSEcCtD
Norfloxacin—Hypoaesthesia—Estradiol—osteoporosis	0.000313	0.00101	CcSEcCtD
Norfloxacin—Angioedema—Conjugated Estrogens—osteoporosis	0.000313	0.001	CcSEcCtD
Norfloxacin—Hypersensitivity—Estropipate—osteoporosis	0.000311	0.001	CcSEcCtD
Norfloxacin—Thrombocytopenia—Pamidronate—osteoporosis	0.000311	0.000999	CcSEcCtD
Norfloxacin—Vomiting—Etidronic acid—osteoporosis	0.000311	0.000998	CcSEcCtD
Norfloxacin—Rash—Etidronic acid—osteoporosis	0.000308	0.00099	CcSEcCtD
Norfloxacin—Convulsion—Zoledronate—osteoporosis	0.000308	0.000989	CcSEcCtD
Norfloxacin—Dermatitis—Etidronic acid—osteoporosis	0.000308	0.000989	CcSEcCtD
Norfloxacin—Vertigo—Conjugated Estrogens—osteoporosis	0.000307	0.000988	CcSEcCtD
Norfloxacin—Hyperhidrosis—Pamidronate—osteoporosis	0.000307	0.000986	CcSEcCtD
Norfloxacin—Hypersensitivity—Alendronate—osteoporosis	0.000307	0.000986	CcSEcCtD
Norfloxacin—Headache—Etidronic acid—osteoporosis	0.000306	0.000983	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000304	0.000978	CcSEcCtD
Norfloxacin—Asthenia—Estropipate—osteoporosis	0.000303	0.000974	CcSEcCtD
Norfloxacin—Visual impairment—Estradiol—osteoporosis	0.000303	0.000974	CcSEcCtD
Norfloxacin—Anorexia—Pamidronate—osteoporosis	0.000303	0.000973	CcSEcCtD
Norfloxacin—Chest pain—Zoledronate—osteoporosis	0.000302	0.000972	CcSEcCtD
Norfloxacin—Arthralgia—Zoledronate—osteoporosis	0.000302	0.000972	CcSEcCtD
Norfloxacin—Myalgia—Zoledronate—osteoporosis	0.000302	0.000972	CcSEcCtD
Norfloxacin—Palpitations—Conjugated Estrogens—osteoporosis	0.000302	0.000972	CcSEcCtD
Norfloxacin—Insomnia—Risedronate—osteoporosis	0.000302	0.000971	CcSEcCtD
Norfloxacin—Anxiety—Zoledronate—osteoporosis	0.000301	0.000969	CcSEcCtD
Norfloxacin—Paraesthesia—Risedronate—osteoporosis	0.0003	0.000964	CcSEcCtD
Norfloxacin—Pruritus—Estropipate—osteoporosis	0.000299	0.000961	CcSEcCtD
Norfloxacin—Asthenia—Alendronate—osteoporosis	0.000299	0.00096	CcSEcCtD
Norfloxacin—Hypersensitivity—Ibandronate—osteoporosis	0.000298	0.00096	CcSEcCtD
Norfloxacin—Dyspnoea—Risedronate—osteoporosis	0.000298	0.000957	CcSEcCtD
Norfloxacin—Erythema multiforme—Estradiol—osteoporosis	0.000297	0.000956	CcSEcCtD
Norfloxacin—Convulsion—Conjugated Estrogens—osteoporosis	0.000296	0.000953	CcSEcCtD
Norfloxacin—Dry mouth—Zoledronate—osteoporosis	0.000296	0.000951	CcSEcCtD
Norfloxacin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000295	0.000949	CcSEcCtD
Norfloxacin—Pruritus—Alendronate—osteoporosis	0.000294	0.000946	CcSEcCtD
Norfloxacin—Dyspepsia—Risedronate—osteoporosis	0.000294	0.000945	CcSEcCtD
Norfloxacin—Tinnitus—Estradiol—osteoporosis	0.000293	0.000943	CcSEcCtD
Norfloxacin—Constipation—Ethinyl Estradiol—osteoporosis	0.000293	0.000941	CcSEcCtD
Norfloxacin—Confusional state—Zoledronate—osteoporosis	0.000292	0.00094	CcSEcCtD
Norfloxacin—Hypersensitivity—Calcitriol—osteoporosis	0.000292	0.000939	CcSEcCtD
Norfloxacin—Chest pain—Conjugated Estrogens—osteoporosis	0.000291	0.000936	CcSEcCtD
Norfloxacin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000291	0.000936	CcSEcCtD
Norfloxacin—Myalgia—Conjugated Estrogens—osteoporosis	0.000291	0.000936	CcSEcCtD
Norfloxacin—Asthenia—Ibandronate—osteoporosis	0.000291	0.000934	CcSEcCtD
Norfloxacin—Anxiety—Conjugated Estrogens—osteoporosis	0.00029	0.000933	CcSEcCtD
Norfloxacin—Nausea—Etidronic acid—osteoporosis	0.00029	0.000932	CcSEcCtD
Norfloxacin—Anaphylactic shock—Zoledronate—osteoporosis	0.00029	0.000932	CcSEcCtD
Norfloxacin—Oedema—Zoledronate—osteoporosis	0.00029	0.000932	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000289	0.00093	CcSEcCtD
Norfloxacin—Diarrhoea—Estropipate—osteoporosis	0.000289	0.000929	CcSEcCtD
Norfloxacin—Fatigue—Risedronate—osteoporosis	0.000288	0.000925	CcSEcCtD
Norfloxacin—Insomnia—Pamidronate—osteoporosis	0.000287	0.000923	CcSEcCtD
Norfloxacin—Pruritus—Ibandronate—osteoporosis	0.000287	0.000921	CcSEcCtD
Norfloxacin—Constipation—Risedronate—osteoporosis	0.000286	0.000918	CcSEcCtD
Norfloxacin—Paraesthesia—Pamidronate—osteoporosis	0.000285	0.000916	CcSEcCtD
Norfloxacin—Diarrhoea—Alendronate—osteoporosis	0.000285	0.000915	CcSEcCtD
Norfloxacin—Asthenia—Calcitriol—osteoporosis	0.000285	0.000915	CcSEcCtD
Norfloxacin—Thrombocytopenia—Zoledronate—osteoporosis	0.000284	0.000912	CcSEcCtD
Norfloxacin—Dyspnoea—Pamidronate—osteoporosis	0.000283	0.00091	CcSEcCtD
Norfloxacin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000282	0.000907	CcSEcCtD
Norfloxacin—Chills—Estradiol—osteoporosis	0.000282	0.000907	CcSEcCtD
Norfloxacin—Somnolence—Pamidronate—osteoporosis	0.000282	0.000907	CcSEcCtD
Norfloxacin—Pruritus—Calcitriol—osteoporosis	0.000281	0.000902	CcSEcCtD
Norfloxacin—Hyperhidrosis—Zoledronate—osteoporosis	0.00028	0.000901	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00028	0.0009	CcSEcCtD
Norfloxacin—Diarrhoea—Raloxifene—osteoporosis	0.00028	0.0009	CcSEcCtD
Norfloxacin—Dyspepsia—Pamidronate—osteoporosis	0.000279	0.000898	CcSEcCtD
Norfloxacin—Dizziness—Estropipate—osteoporosis	0.000279	0.000898	CcSEcCtD
Norfloxacin—Oedema—Conjugated Estrogens—osteoporosis	0.000279	0.000897	CcSEcCtD
Norfloxacin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000279	0.000897	CcSEcCtD
Norfloxacin—Diarrhoea—Ibandronate—osteoporosis	0.000277	0.000891	CcSEcCtD
Norfloxacin—Anorexia—Zoledronate—osteoporosis	0.000276	0.000888	CcSEcCtD
Norfloxacin—Decreased appetite—Pamidronate—osteoporosis	0.000276	0.000887	CcSEcCtD
Norfloxacin—Dizziness—Alendronate—osteoporosis	0.000275	0.000885	CcSEcCtD
Norfloxacin—Erythema—Estradiol—osteoporosis	0.000274	0.00088	CcSEcCtD
Norfloxacin—Fatigue—Pamidronate—osteoporosis	0.000274	0.00088	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Risedronate—osteoporosis	0.000273	0.000878	CcSEcCtD
Norfloxacin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000272	0.000875	CcSEcCtD
Norfloxacin—Constipation—Pamidronate—osteoporosis	0.000271	0.000872	CcSEcCtD
Norfloxacin—Diarrhoea—Calcitriol—osteoporosis	0.000271	0.000872	CcSEcCtD
Norfloxacin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000271	0.00087	CcSEcCtD
Norfloxacin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000271	0.00087	CcSEcCtD
Norfloxacin—Dizziness—Raloxifene—osteoporosis	0.000271	0.00087	CcSEcCtD
Norfloxacin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00027	0.000868	CcSEcCtD
Norfloxacin—Flatulence—Estradiol—osteoporosis	0.00027	0.000867	CcSEcCtD
Norfloxacin—Tension—Estradiol—osteoporosis	0.000269	0.000864	CcSEcCtD
Norfloxacin—Vomiting—Estropipate—osteoporosis	0.000269	0.000864	CcSEcCtD
Norfloxacin—Dysgeusia—Estradiol—osteoporosis	0.000268	0.000862	CcSEcCtD
Norfloxacin—Dizziness—Ibandronate—osteoporosis	0.000268	0.000861	CcSEcCtD
Norfloxacin—Rash—Estropipate—osteoporosis	0.000266	0.000856	CcSEcCtD
Norfloxacin—Dermatitis—Estropipate—osteoporosis	0.000266	0.000856	CcSEcCtD
Norfloxacin—Anorexia—Conjugated Estrogens—osteoporosis	0.000266	0.000855	CcSEcCtD
Norfloxacin—Nervousness—Estradiol—osteoporosis	0.000266	0.000855	CcSEcCtD
Norfloxacin—Urticaria—Risedronate—osteoporosis	0.000265	0.000853	CcSEcCtD
Norfloxacin—Back pain—Estradiol—osteoporosis	0.000265	0.000851	CcSEcCtD
Norfloxacin—Headache—Estropipate—osteoporosis	0.000265	0.000851	CcSEcCtD
Norfloxacin—Vomiting—Alendronate—osteoporosis	0.000265	0.00085	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000264	0.000849	CcSEcCtD
Norfloxacin—Body temperature increased—Risedronate—osteoporosis	0.000264	0.000848	CcSEcCtD
Norfloxacin—Abdominal pain—Risedronate—osteoporosis	0.000264	0.000848	CcSEcCtD
Norfloxacin—Muscle spasms—Estradiol—osteoporosis	0.000263	0.000846	CcSEcCtD
Norfloxacin—Rash—Alendronate—osteoporosis	0.000262	0.000843	CcSEcCtD
Norfloxacin—Insomnia—Zoledronate—osteoporosis	0.000262	0.000843	CcSEcCtD
Norfloxacin—Dermatitis—Alendronate—osteoporosis	0.000262	0.000843	CcSEcCtD
Norfloxacin—Feeling abnormal—Pamidronate—osteoporosis	0.000262	0.000841	CcSEcCtD
Norfloxacin—Headache—Alendronate—osteoporosis	0.000261	0.000838	CcSEcCtD
Norfloxacin—Paraesthesia—Zoledronate—osteoporosis	0.00026	0.000837	CcSEcCtD
Norfloxacin—Vomiting—Raloxifene—osteoporosis	0.00026	0.000836	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Pamidronate—osteoporosis	0.00026	0.000834	CcSEcCtD
Norfloxacin—Dyspnoea—Zoledronate—osteoporosis	0.000258	0.000831	CcSEcCtD
Norfloxacin—Rash—Raloxifene—osteoporosis	0.000258	0.000829	CcSEcCtD
Norfloxacin—Dermatitis—Raloxifene—osteoporosis	0.000258	0.000829	CcSEcCtD
Norfloxacin—Somnolence—Zoledronate—osteoporosis	0.000258	0.000829	CcSEcCtD
Norfloxacin—Vomiting—Ibandronate—osteoporosis	0.000258	0.000828	CcSEcCtD
Norfloxacin—Tremor—Estradiol—osteoporosis	0.000256	0.000824	CcSEcCtD
Norfloxacin—Headache—Raloxifene—osteoporosis	0.000256	0.000824	CcSEcCtD
Norfloxacin—Rash—Ibandronate—osteoporosis	0.000255	0.000821	CcSEcCtD
Norfloxacin—Dermatitis—Ibandronate—osteoporosis	0.000255	0.00082	CcSEcCtD
Norfloxacin—Dyspepsia—Zoledronate—osteoporosis	0.000255	0.00082	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000254	0.000818	CcSEcCtD
Norfloxacin—Headache—Ibandronate—osteoporosis	0.000254	0.000816	CcSEcCtD
Norfloxacin—Insomnia—Conjugated Estrogens—osteoporosis	0.000252	0.000812	CcSEcCtD
Norfloxacin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000252	0.000811	CcSEcCtD
Norfloxacin—Vomiting—Calcitriol—osteoporosis	0.000252	0.000811	CcSEcCtD
Norfloxacin—Decreased appetite—Zoledronate—osteoporosis	0.000252	0.00081	CcSEcCtD
Norfloxacin—Agitation—Estradiol—osteoporosis	0.000252	0.000809	CcSEcCtD
Norfloxacin—Nausea—Estropipate—osteoporosis	0.000251	0.000807	CcSEcCtD
Norfloxacin—Abdominal pain—Pamidronate—osteoporosis	0.000251	0.000807	CcSEcCtD
Norfloxacin—Body temperature increased—Pamidronate—osteoporosis	0.000251	0.000807	CcSEcCtD
Norfloxacin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000251	0.000806	CcSEcCtD
Norfloxacin—Angioedema—Estradiol—osteoporosis	0.00025	0.000804	CcSEcCtD
Norfloxacin—Rash—Calcitriol—osteoporosis	0.00025	0.000804	CcSEcCtD
Norfloxacin—Fatigue—Zoledronate—osteoporosis	0.00025	0.000803	CcSEcCtD
Norfloxacin—Dermatitis—Calcitriol—osteoporosis	0.00025	0.000803	CcSEcCtD
Norfloxacin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000249	0.0008	CcSEcCtD
Norfloxacin—Headache—Calcitriol—osteoporosis	0.000248	0.000799	CcSEcCtD
Norfloxacin—Somnolence—Conjugated Estrogens—osteoporosis	0.000248	0.000798	CcSEcCtD
Norfloxacin—Constipation—Zoledronate—osteoporosis	0.000248	0.000797	CcSEcCtD
Norfloxacin—Nausea—Alendronate—osteoporosis	0.000247	0.000795	CcSEcCtD
Norfloxacin—Hypersensitivity—Risedronate—osteoporosis	0.000246	0.000791	CcSEcCtD
Norfloxacin—Vertigo—Estradiol—osteoporosis	0.000246	0.000791	CcSEcCtD
Norfloxacin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000246	0.00079	CcSEcCtD
Norfloxacin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000246	0.00079	CcSEcCtD
Norfloxacin—Nausea—Raloxifene—osteoporosis	0.000243	0.000781	CcSEcCtD
Norfloxacin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000243	0.00078	CcSEcCtD
Norfloxacin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000242	0.000779	CcSEcCtD
Norfloxacin—Palpitations—Estradiol—osteoporosis	0.000242	0.000778	CcSEcCtD
Norfloxacin—Fatigue—Conjugated Estrogens—osteoporosis	0.000241	0.000774	CcSEcCtD
Norfloxacin—Nausea—Ibandronate—osteoporosis	0.000241	0.000774	CcSEcCtD
Norfloxacin—Asthenia—Risedronate—osteoporosis	0.00024	0.00077	CcSEcCtD
Norfloxacin—Feeling abnormal—Zoledronate—osteoporosis	0.000239	0.000768	CcSEcCtD
Norfloxacin—Constipation—Conjugated Estrogens—osteoporosis	0.000239	0.000767	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000237	0.000762	CcSEcCtD
Norfloxacin—Pruritus—Risedronate—osteoporosis	0.000236	0.000759	CcSEcCtD
Norfloxacin—Nausea—Calcitriol—osteoporosis	0.000236	0.000757	CcSEcCtD
Norfloxacin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000234	0.000753	CcSEcCtD
Norfloxacin—Hypersensitivity—Pamidronate—osteoporosis	0.000234	0.000752	CcSEcCtD
Norfloxacin—Arthralgia—Estradiol—osteoporosis	0.000233	0.000749	CcSEcCtD
Norfloxacin—Myalgia—Estradiol—osteoporosis	0.000233	0.000749	CcSEcCtD
Norfloxacin—Chest pain—Estradiol—osteoporosis	0.000233	0.000749	CcSEcCtD
Norfloxacin—Anxiety—Estradiol—osteoporosis	0.000232	0.000747	CcSEcCtD
Norfloxacin—Urticaria—Zoledronate—osteoporosis	0.00023	0.00074	CcSEcCtD
Norfloxacin—Abdominal pain—Zoledronate—osteoporosis	0.000229	0.000737	CcSEcCtD
Norfloxacin—Body temperature increased—Zoledronate—osteoporosis	0.000229	0.000737	CcSEcCtD
Norfloxacin—Diarrhoea—Risedronate—osteoporosis	0.000228	0.000734	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000228	0.000734	CcSEcCtD
Norfloxacin—Dry mouth—Estradiol—osteoporosis	0.000228	0.000733	CcSEcCtD
Norfloxacin—Asthenia—Pamidronate—osteoporosis	0.000228	0.000732	CcSEcCtD
Norfloxacin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000226	0.000728	CcSEcCtD
Norfloxacin—Confusional state—Estradiol—osteoporosis	0.000225	0.000724	CcSEcCtD
Norfloxacin—Pruritus—Pamidronate—osteoporosis	0.000225	0.000722	CcSEcCtD
Norfloxacin—Oedema—Estradiol—osteoporosis	0.000223	0.000718	CcSEcCtD
Norfloxacin—Anaphylactic shock—Estradiol—osteoporosis	0.000223	0.000718	CcSEcCtD
Norfloxacin—Urticaria—Conjugated Estrogens—osteoporosis	0.000222	0.000713	CcSEcCtD
Norfloxacin—Dizziness—Risedronate—osteoporosis	0.000221	0.00071	CcSEcCtD
Norfloxacin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000221	0.000709	CcSEcCtD
Norfloxacin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000221	0.000709	CcSEcCtD
Norfloxacin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000218	0.0007	CcSEcCtD
Norfloxacin—Diarrhoea—Pamidronate—osteoporosis	0.000217	0.000698	CcSEcCtD
Norfloxacin—Hyperhidrosis—Estradiol—osteoporosis	0.000216	0.000694	CcSEcCtD
Norfloxacin—Rash—Ethinyl Estradiol—osteoporosis	0.000216	0.000694	CcSEcCtD
Norfloxacin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000216	0.000693	CcSEcCtD
Norfloxacin—Headache—Ethinyl Estradiol—osteoporosis	0.000215	0.00069	CcSEcCtD
Norfloxacin—Hypersensitivity—Zoledronate—osteoporosis	0.000214	0.000687	CcSEcCtD
Norfloxacin—Vomiting—Risedronate—osteoporosis	0.000212	0.000682	CcSEcCtD
Norfloxacin—Rash—Risedronate—osteoporosis	0.000211	0.000677	CcSEcCtD
Norfloxacin—Dermatitis—Risedronate—osteoporosis	0.00021	0.000676	CcSEcCtD
Norfloxacin—Dizziness—Pamidronate—osteoporosis	0.00021	0.000675	CcSEcCtD
Norfloxacin—Headache—Risedronate—osteoporosis	0.000209	0.000672	CcSEcCtD
Norfloxacin—Asthenia—Zoledronate—osteoporosis	0.000208	0.000669	CcSEcCtD
Norfloxacin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000206	0.000661	CcSEcCtD
Norfloxacin—Pruritus—Zoledronate—osteoporosis	0.000205	0.000659	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000204	0.000654	CcSEcCtD
Norfloxacin—Nausea—Ethinyl Estradiol—osteoporosis	0.000203	0.000654	CcSEcCtD
Norfloxacin—Insomnia—Estradiol—osteoporosis	0.000202	0.00065	CcSEcCtD
Norfloxacin—Vomiting—Pamidronate—osteoporosis	0.000202	0.000649	CcSEcCtD
Norfloxacin—Paraesthesia—Estradiol—osteoporosis	0.000201	0.000645	CcSEcCtD
Norfloxacin—Asthenia—Conjugated Estrogens—osteoporosis	0.0002	0.000644	CcSEcCtD
Norfloxacin—Rash—Pamidronate—osteoporosis	0.0002	0.000643	CcSEcCtD
Norfloxacin—Dermatitis—Pamidronate—osteoporosis	0.0002	0.000643	CcSEcCtD
Norfloxacin—Dyspnoea—Estradiol—osteoporosis	0.000199	0.00064	CcSEcCtD
Norfloxacin—Headache—Pamidronate—osteoporosis	0.000199	0.000639	CcSEcCtD
Norfloxacin—Somnolence—Estradiol—osteoporosis	0.000199	0.000638	CcSEcCtD
Norfloxacin—Diarrhoea—Zoledronate—osteoporosis	0.000198	0.000638	CcSEcCtD
Norfloxacin—Nausea—Risedronate—osteoporosis	0.000198	0.000638	CcSEcCtD
Norfloxacin—Pruritus—Conjugated Estrogens—osteoporosis	0.000198	0.000635	CcSEcCtD
Norfloxacin—Dyspepsia—Estradiol—osteoporosis	0.000197	0.000632	CcSEcCtD
Norfloxacin—Decreased appetite—Estradiol—osteoporosis	0.000194	0.000624	CcSEcCtD
Norfloxacin—Fatigue—Estradiol—osteoporosis	0.000193	0.000619	CcSEcCtD
Norfloxacin—Dizziness—Zoledronate—osteoporosis	0.000192	0.000616	CcSEcCtD
Norfloxacin—Constipation—Estradiol—osteoporosis	0.000191	0.000614	CcSEcCtD
Norfloxacin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000191	0.000614	CcSEcCtD
Norfloxacin—Nausea—Pamidronate—osteoporosis	0.000189	0.000606	CcSEcCtD
Norfloxacin—Dizziness—Conjugated Estrogens—osteoporosis	0.000185	0.000593	CcSEcCtD
Norfloxacin—Vomiting—Zoledronate—osteoporosis	0.000184	0.000593	CcSEcCtD
Norfloxacin—Feeling abnormal—Estradiol—osteoporosis	0.000184	0.000592	CcSEcCtD
Norfloxacin—Rash—Zoledronate—osteoporosis	0.000183	0.000588	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Estradiol—osteoporosis	0.000183	0.000587	CcSEcCtD
Norfloxacin—Dermatitis—Zoledronate—osteoporosis	0.000183	0.000587	CcSEcCtD
Norfloxacin—Headache—Zoledronate—osteoporosis	0.000182	0.000584	CcSEcCtD
Norfloxacin—Vomiting—Conjugated Estrogens—osteoporosis	0.000177	0.000571	CcSEcCtD
Norfloxacin—Urticaria—Estradiol—osteoporosis	0.000177	0.000571	CcSEcCtD
Norfloxacin—Body temperature increased—Estradiol—osteoporosis	0.000177	0.000568	CcSEcCtD
Norfloxacin—Abdominal pain—Estradiol—osteoporosis	0.000177	0.000568	CcSEcCtD
Norfloxacin—Rash—Conjugated Estrogens—osteoporosis	0.000176	0.000566	CcSEcCtD
Norfloxacin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000176	0.000565	CcSEcCtD
Norfloxacin—Headache—Conjugated Estrogens—osteoporosis	0.000175	0.000562	CcSEcCtD
Norfloxacin—Nausea—Zoledronate—osteoporosis	0.000172	0.000554	CcSEcCtD
Norfloxacin—Nausea—Conjugated Estrogens—osteoporosis	0.000166	0.000533	CcSEcCtD
Norfloxacin—Hypersensitivity—Estradiol—osteoporosis	0.000165	0.000529	CcSEcCtD
Norfloxacin—Asthenia—Estradiol—osteoporosis	0.00016	0.000515	CcSEcCtD
Norfloxacin—Pruritus—Estradiol—osteoporosis	0.000158	0.000508	CcSEcCtD
Norfloxacin—Diarrhoea—Estradiol—osteoporosis	0.000153	0.000491	CcSEcCtD
Norfloxacin—Dizziness—Estradiol—osteoporosis	0.000148	0.000475	CcSEcCtD
Norfloxacin—Vomiting—Estradiol—osteoporosis	0.000142	0.000457	CcSEcCtD
Norfloxacin—Rash—Estradiol—osteoporosis	0.000141	0.000453	CcSEcCtD
Norfloxacin—Dermatitis—Estradiol—osteoporosis	0.000141	0.000452	CcSEcCtD
Norfloxacin—Headache—Estradiol—osteoporosis	0.00014	0.00045	CcSEcCtD
Norfloxacin—Nausea—Estradiol—osteoporosis	0.000133	0.000427	CcSEcCtD
Norfloxacin—CYP1A1—Arachidonic acid metabolism—GPX1—osteoporosis	1.72e-05	0.0063	CbGpPWpGaD
Norfloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	1.71e-05	0.00626	CbGpPWpGaD
Norfloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	1.68e-05	0.00618	CbGpPWpGaD
Norfloxacin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	1.61e-05	0.0059	CbGpPWpGaD
Norfloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.6e-05	0.00588	CbGpPWpGaD
Norfloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.6e-05	0.00587	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	1.58e-05	0.0058	CbGpPWpGaD
Norfloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.56e-05	0.00573	CbGpPWpGaD
Norfloxacin—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	1.56e-05	0.00572	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	1.5e-05	0.00552	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—CYP27A1—osteoporosis	1.49e-05	0.00548	CbGpPWpGaD
Norfloxacin—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.48e-05	0.00542	CbGpPWpGaD
Norfloxacin—CYP1A1—Metapathway biotransformation—CYP27A1—osteoporosis	1.47e-05	0.0054	CbGpPWpGaD
Norfloxacin—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.47e-05	0.00539	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.45e-05	0.00532	CbGpPWpGaD
Norfloxacin—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	1.44e-05	0.00527	CbGpPWpGaD
Norfloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.38e-05	0.00507	CbGpPWpGaD
Norfloxacin—CYP3A7—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.3e-05	0.00477	CbGpPWpGaD
Norfloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.23e-05	0.00453	CbGpPWpGaD
Norfloxacin—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.19e-05	0.00437	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—LEP—osteoporosis	1.17e-05	0.00431	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.17e-05	0.00429	CbGpPWpGaD
Norfloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.16e-05	0.00426	CbGpPWpGaD
Norfloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.16e-05	0.00425	CbGpPWpGaD
Norfloxacin—CYP3A7—Biological oxidations—CYP19A1—osteoporosis	1.15e-05	0.00421	CbGpPWpGaD
Norfloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.15e-05	0.0042	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	1.14e-05	0.00418	CbGpPWpGaD
Norfloxacin—CYP3A7—Metapathway biotransformation—CYP19A1—osteoporosis	1.13e-05	0.00416	CbGpPWpGaD
Norfloxacin—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	1.11e-05	0.00407	CbGpPWpGaD
Norfloxacin—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.09e-05	0.00402	CbGpPWpGaD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	1.09e-05	0.00401	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.09e-05	0.00401	CbGpPWpGaD
Norfloxacin—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	1.05e-05	0.00386	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—PSMA5—osteoporosis	1.04e-05	0.00383	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—PSMA2—osteoporosis	1.04e-05	0.00383	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.01e-05	0.00371	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	1e-05	0.00369	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.98e-06	0.00366	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—AGER—osteoporosis	9.84e-06	0.00361	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	9.59e-06	0.00352	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	9.52e-06	0.00349	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.46e-06	0.00347	CbGpPWpGaD
Norfloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.41e-06	0.00345	CbGpPWpGaD
Norfloxacin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.39e-06	0.00345	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	9.39e-06	0.00344	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—PSMA2—osteoporosis	9.33e-06	0.00342	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—PSMA5—osteoporosis	9.33e-06	0.00342	CbGpPWpGaD
Norfloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.96e-06	0.00329	CbGpPWpGaD
Norfloxacin—CYP1A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.87e-06	0.00326	CbGpPWpGaD
Norfloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.84e-06	0.00324	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	8.3e-06	0.00305	CbGpPWpGaD
Norfloxacin—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	8.19e-06	0.003	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—osteoporosis	8.02e-06	0.00294	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—CYP19A1—osteoporosis	7.84e-06	0.00288	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	7.83e-06	0.00287	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	7.81e-06	0.00286	CbGpPWpGaD
Norfloxacin—CYP1A1—Metapathway biotransformation—CYP19A1—osteoporosis	7.73e-06	0.00284	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.36e-06	0.0027	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	7.35e-06	0.0027	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	7.29e-06	0.00267	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	7.29e-06	0.00267	CbGpPWpGaD
Norfloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.27e-06	0.00267	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	7.25e-06	0.00266	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.17e-06	0.00263	CbGpPWpGaD
Norfloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.98e-06	0.00256	CbGpPWpGaD
Norfloxacin—CYP3A7—Biological oxidations—POMC—osteoporosis	6.9e-06	0.00253	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PKM—osteoporosis	6.51e-06	0.00239	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—FDPS—osteoporosis	6.51e-06	0.00239	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	6.41e-06	0.00235	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.36e-06	0.00234	CbGpPWpGaD
Norfloxacin—CYP2A6—Biological oxidations—POMC—osteoporosis	6.33e-06	0.00232	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PGLS—osteoporosis	6.17e-06	0.00226	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GPD2—osteoporosis	6.17e-06	0.00226	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.08e-06	0.00223	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.06e-06	0.00222	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.03e-06	0.00221	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PKM—osteoporosis	5.97e-06	0.00219	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—FDPS—osteoporosis	5.97e-06	0.00219	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.73e-06	0.0021	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.66e-06	0.00208	CbGpPWpGaD
Norfloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.66e-06	0.00208	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GPD2—osteoporosis	5.66e-06	0.00208	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PGLS—osteoporosis	5.66e-06	0.00208	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ATIC—osteoporosis	5.64e-06	0.00207	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PNP—osteoporosis	5.64e-06	0.00207	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.44e-06	0.00199	CbGpPWpGaD
Norfloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.39e-06	0.00198	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ATIC—osteoporosis	5.17e-06	0.0019	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PNP—osteoporosis	5.17e-06	0.0019	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	5e-06	0.00183	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	4.99e-06	0.00183	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—POMC—osteoporosis	4.99e-06	0.00183	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	4.98e-06	0.00183	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	4.93e-06	0.00181	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.87e-06	0.00179	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CA2—osteoporosis	4.8e-06	0.00176	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—OXCT1—osteoporosis	4.8e-06	0.00176	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—POMC—osteoporosis	4.71e-06	0.00173	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PKM—osteoporosis	4.71e-06	0.00173	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—FDPS—osteoporosis	4.71e-06	0.00173	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.69e-06	0.00172	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MGLL—osteoporosis	4.68e-06	0.00172	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	4.65e-06	0.00171	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	4.65e-06	0.00171	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.57e-06	0.00168	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PGLS—osteoporosis	4.46e-06	0.00164	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GPD2—osteoporosis	4.46e-06	0.00164	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PKM—osteoporosis	4.45e-06	0.00163	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—FDPS—osteoporosis	4.45e-06	0.00163	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CA2—osteoporosis	4.4e-06	0.00161	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—OXCT1—osteoporosis	4.4e-06	0.00161	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—IL6—osteoporosis	4.39e-06	0.00161	CbGpPWpGaD
Norfloxacin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.37e-06	0.0016	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MGLL—osteoporosis	4.29e-06	0.00157	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GPD2—osteoporosis	4.21e-06	0.00155	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PGLS—osteoporosis	4.21e-06	0.00155	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	4.16e-06	0.00153	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.1e-06	0.00151	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PNP—osteoporosis	4.08e-06	0.0015	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ATIC—osteoporosis	4.08e-06	0.0015	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—IDH2—osteoporosis	3.98e-06	0.00146	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.86e-06	0.00142	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ATIC—osteoporosis	3.85e-06	0.00141	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PNP—osteoporosis	3.85e-06	0.00141	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.81e-06	0.0014	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP27A1—osteoporosis	3.74e-06	0.00137	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.66e-06	0.00134	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—IDH2—osteoporosis	3.64e-06	0.00134	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ACP5—osteoporosis	3.64e-06	0.00133	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CA2—osteoporosis	3.47e-06	0.00127	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—OXCT1—osteoporosis	3.47e-06	0.00127	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP27A1—osteoporosis	3.43e-06	0.00126	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—TPI1—osteoporosis	3.38e-06	0.00124	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MGLL—osteoporosis	3.38e-06	0.00124	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ACP5—osteoporosis	3.33e-06	0.00122	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CA2—osteoporosis	3.28e-06	0.0012	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—OXCT1—osteoporosis	3.28e-06	0.0012	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MGLL—osteoporosis	3.19e-06	0.00117	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—P4HB—osteoporosis	3.18e-06	0.00117	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GAPDH—osteoporosis	3.12e-06	0.00114	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.11e-06	0.00114	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TPI1—osteoporosis	3.1e-06	0.00114	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—RAP1A—osteoporosis	3.04e-06	0.00111	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.01e-06	0.0011	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—POMC—osteoporosis	3.01e-06	0.0011	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—osteoporosis	2.94e-06	0.00108	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—P4HB—osteoporosis	2.91e-06	0.00107	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—IDH2—osteoporosis	2.87e-06	0.00105	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GAPDH—osteoporosis	2.86e-06	0.00105	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PKM—osteoporosis	2.83e-06	0.00104	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—FDPS—osteoporosis	2.83e-06	0.00104	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—RAP1A—osteoporosis	2.79e-06	0.00102	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—IDH2—osteoporosis	2.72e-06	0.000996	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.7e-06	0.000992	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GPD2—osteoporosis	2.69e-06	0.000986	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PGLS—osteoporosis	2.69e-06	0.000986	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYC—osteoporosis	2.63e-06	0.000965	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ACP5—osteoporosis	2.63e-06	0.000965	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP27A1—osteoporosis	2.55e-06	0.000937	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ACP5—osteoporosis	2.48e-06	0.000911	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ATIC—osteoporosis	2.46e-06	0.000902	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PNP—osteoporosis	2.46e-06	0.000902	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ENO1—osteoporosis	2.46e-06	0.000901	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.45e-06	0.0009	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TPI1—osteoporosis	2.44e-06	0.000897	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PSMA5—osteoporosis	2.42e-06	0.000888	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PSMA2—osteoporosis	2.42e-06	0.000888	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—POMC—osteoporosis	2.32e-06	0.000851	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TPI1—osteoporosis	2.31e-06	0.000847	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—P4HB—osteoporosis	2.3e-06	0.000843	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GAPDH—osteoporosis	2.26e-06	0.000828	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ENO1—osteoporosis	2.25e-06	0.000826	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PSMA2—osteoporosis	2.22e-06	0.000814	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PSMA5—osteoporosis	2.22e-06	0.000814	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—RAP1A—osteoporosis	2.2e-06	0.000806	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—FDPS—osteoporosis	2.19e-06	0.000803	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PKM—osteoporosis	2.19e-06	0.000803	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—P4HB—osteoporosis	2.17e-06	0.000796	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GAPDH—osteoporosis	2.13e-06	0.000782	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—OXCT1—osteoporosis	2.09e-06	0.000767	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA2—osteoporosis	2.09e-06	0.000767	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—RAP1A—osteoporosis	2.08e-06	0.000761	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PGLS—osteoporosis	2.07e-06	0.000761	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GPD2—osteoporosis	2.07e-06	0.000761	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MGLL—osteoporosis	2.04e-06	0.000747	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.96e-06	0.000721	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.92e-06	0.000705	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ATIC—osteoporosis	1.9e-06	0.000696	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PNP—osteoporosis	1.9e-06	0.000696	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.81e-06	0.000664	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP19A1—osteoporosis	1.8e-06	0.00066	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ENO1—osteoporosis	1.78e-06	0.000652	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PSMA5—osteoporosis	1.75e-06	0.000642	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PSMA2—osteoporosis	1.75e-06	0.000642	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—IDH2—osteoporosis	1.73e-06	0.000635	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ENO1—osteoporosis	1.68e-06	0.000616	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSMA2—osteoporosis	1.65e-06	0.000607	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSMA5—osteoporosis	1.65e-06	0.000607	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.63e-06	0.000597	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA2—osteoporosis	1.61e-06	0.000592	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—OXCT1—osteoporosis	1.61e-06	0.000592	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ADCY5—osteoporosis	1.6e-06	0.000589	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GPX1—osteoporosis	1.6e-06	0.000587	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ACP5—osteoporosis	1.58e-06	0.000581	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MGLL—osteoporosis	1.57e-06	0.000577	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.56e-06	0.000574	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MTHFR—osteoporosis	1.48e-06	0.000541	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TPI1—osteoporosis	1.47e-06	0.00054	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ADCY5—osteoporosis	1.47e-06	0.00054	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GPX1—osteoporosis	1.47e-06	0.000538	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.42e-06	0.000521	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—P4HB—osteoporosis	1.38e-06	0.000508	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GAPDH—osteoporosis	1.36e-06	0.000498	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MTHFR—osteoporosis	1.35e-06	0.000496	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP19A1—osteoporosis	1.34e-06	0.000492	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—IDH2—osteoporosis	1.34e-06	0.00049	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—RAP1A—osteoporosis	1.32e-06	0.000486	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.26e-06	0.000461	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ACP5—osteoporosis	1.22e-06	0.000448	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—POMC—osteoporosis	1.18e-06	0.000433	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ADCY5—osteoporosis	1.16e-06	0.000426	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GPX1—osteoporosis	1.16e-06	0.000424	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.15e-06	0.000423	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TPI1—osteoporosis	1.14e-06	0.000417	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ADCY5—osteoporosis	1.1e-06	0.000402	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GPX1—osteoporosis	1.09e-06	0.000401	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—POMC—osteoporosis	1.08e-06	0.000397	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ENO1—osteoporosis	1.07e-06	0.000392	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—P4HB—osteoporosis	1.07e-06	0.000392	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MTHFR—osteoporosis	1.07e-06	0.000391	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSMA5—osteoporosis	1.05e-06	0.000387	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSMA2—osteoporosis	1.05e-06	0.000387	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GAPDH—osteoporosis	1.05e-06	0.000385	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—RAP1A—osteoporosis	1.02e-06	0.000375	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MTHFR—osteoporosis	1.01e-06	0.00037	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP19A1—osteoporosis	8.55e-07	0.000314	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—POMC—osteoporosis	8.53e-07	0.000313	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ENO1—osteoporosis	8.26e-07	0.000303	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSMA2—osteoporosis	8.13e-07	0.000298	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSMA5—osteoporosis	8.13e-07	0.000298	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—POMC—osteoporosis	8.06e-07	0.000296	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADCY5—osteoporosis	6.99e-07	0.000256	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GPX1—osteoporosis	6.96e-07	0.000255	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.6e-07	0.000242	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTHFR—osteoporosis	6.43e-07	0.000236	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADCY5—osteoporosis	5.39e-07	0.000198	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GPX1—osteoporosis	5.37e-07	0.000197	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—POMC—osteoporosis	5.14e-07	0.000189	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTHFR—osteoporosis	4.96e-07	0.000182	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—POMC—osteoporosis	3.97e-07	0.000146	CbGpPWpGaD
